Autophagy modulation: a target for cancer treatment development.
about
Oncolytic viruses as immunotherapy: progress and remaining challengesThe Warburg effect and drug resistanceAutophagy in colorectal cancer: An important switch from physiology to pathologyPre-clinical evaluation of a novel class of anti-cancer agents, the Pyrrolo-1, 5-benzoxazepinesCaspase-3 controls AML1-ETO-driven leukemogenesis via autophagy modulation in a ULK1-dependent mannerInfluence of the proton pump inhibitor lansoprazole on distribution and activity of doxorubicin in solid tumors.A strategy to combine pathway-targeted low toxicity drugs in ovarian cancerEssential role for acid sphingomyelinase-inhibited autophagy in melanoma response to cisplatin.Erianin induces G2/M-phase arrest, apoptosis, and autophagy via the ROS/JNK signaling pathway in human osteosarcoma cells in vitro and in vivo.JNK1 Inhibition Attenuates Hypoxia-Induced Autophagy and Sensitizes to Chemotherapy.A new function for miRNAs as regulators of autophagy.The oncolytic virus ΔPK has multimodal anti-tumor activity.Autophagy is not uniformly cytoprotective: a personalized medicine approach for autophagy inhibition as a therapeutic strategy in non-small cell lung cancer.PLK1 (polo like kinase 1) inhibits MTOR complex 1 and promotes autophagy.Cytokines in immunogenic cell death: Applications for cancer immunotherapy.NPM1 Mutant Mediated PML Delocalization and Stabilization Enhances Autophagy and Cell Survival in Leukemic Cells.Expression analysis of LC3B and p62 indicates intact activated autophagy is associated with an unfavorable prognosis in colon cancer.ATG7 promotes the tumorigenesis of lung cancer but might be dispensable for prognosis predication: a clinicopathologic studyAutophagy inhibition upregulates CD4+ tumor infiltrating lymphocyte expression via miR-155 regulation and TRAIL activationPrognostic relevance of autophagy-related markers LC3, p62/sequestosome 1, Beclin-1 and ULK1 in colorectal cancer patients with respect to KRAS mutational status.Inhibition of autophagy initiation potentiates chemosensitivity in mesothelioma.Autophagy suppresses proliferation of HepG2 cells via inhibiting glypican-3/wnt/β-catenin signaling.Quinacrine upregulates p21/p27 independent of p53 through autophagy-mediated downregulation of p62-Skp2 axis in ovarian cancer.Cantharidin suppresses cell growth and migration, and activates autophagy in human non-small cell lung cancer cells.Melanoma Cell Death MechanismsHigh expression of GALNT7 promotes invasion and proliferation of glioma cellsTFDP3 regulates the apoptosis and autophagy in breast cancer cell line MDA-MB-231Expression Analysis of Autophagy Related Markers LC3B, p62 and HMGB1 Indicate an Autophagy-Independent Negative Prognostic Impact of High p62 Expression in Pulmonary Squamous Cell CarcinomasMAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma
P2860
Q26745942-D29D71BE-E93F-4384-9CF7-DDB0E6751943Q26770007-A95250ED-9296-4E01-852F-7CFA00F317BCQ26776207-25160AA6-F91F-482E-A659-B02746B6C2A9Q28078909-E4C765D9-17E1-4C40-9AFB-38560443461BQ33707343-AFC06770-693E-4BD0-A0DA-DC93018E23A3Q36262935-2A03A035-91FC-4063-A162-59C905FA4F07Q36544506-DE1A61B2-F274-43E7-B716-CAA141F37819Q37295253-73179F7E-6C3F-473E-B716-46B0B36740BFQ37482734-D2980E70-5C99-440D-BDC1-C0B0D1BB4261Q38769076-D671A228-4E02-42E0-8C9E-E7A3B5777B5FQ38783633-A0E367AB-9788-4666-9AA5-8409CEF3476BQ38848885-03B35BA8-84BE-4910-9A09-7C1DDF797570Q38868651-741A821F-1934-42E4-9315-61B7A0DD73B3Q39012724-8683BF6D-F9F7-4F23-ADA1-9C37FB627686Q39397491-2259D060-D3BA-4106-80E4-0866392F5217Q40980425-C76FA90A-FA34-4940-9AFE-B73CC14C0336Q41551291-417133CD-F964-4F67-9414-A6FBC48C46A2Q41753200-0B58525F-D96F-47A6-B792-400F08548329Q41914210-CE7C4F56-0B37-4493-9E92-01B88FDCC585Q42408152-E95446F1-CD65-40BA-A18A-E58180AE57CDQ46044385-3E155602-C927-4DAA-9D2D-4595E14F3A13Q49594048-1FF82920-06B8-4373-A9EA-CEF872C31BF2Q50148114-777247A7-34EC-4347-810B-E6DB15980A99Q54112047-74B2AF0C-56DD-4047-A352-348BA06B1556Q57120881-0812BDAC-5C38-43DD-96C8-CF8E9BC9513DQ58572823-7E254ABA-9BF2-4EEA-88B3-4429BE2F6152Q58713638-6B66F650-9230-4EBC-8DFB-8D58E4DD785DQ58726355-1937A85A-6AF3-44C2-9EC6-6716D2FDB646Q58770545-6A64BD11-D7CF-4375-9127-A7AB0DA0D40B
P2860
Autophagy modulation: a target for cancer treatment development.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Autophagy modulation: a target for cancer treatment development.
@en
type
label
Autophagy modulation: a target for cancer treatment development.
@en
prefLabel
Autophagy modulation: a target for cancer treatment development.
@en
P2093
P2860
P1476
Autophagy modulation: a target for cancer treatment development.
@en
P2093
Alison Duffy
Ashkan Emadi
Edward Sausville
Jackson Le
P2860
P2888
P304
P356
10.1007/S00280-014-2637-Z
P577
2014-11-25T00:00:00Z
P6179
1011715533